The storage and use of residual newborn screening dried blood specimens has generated
significant controversy in the past 5 years, primarily because of public concerns over the lack
of parental knowledge and consent for these activities. State policies addressing the
management of these specimens vary widely, and there is currently little guidance to aid
new state policy development to address the concerns of program professionals,
investigators, and the general public. This article offers guidance for state policy based on …